Background Efficacy of sulfadoxine–pyrimethamine, the malaria chemoprophylaxis used in
pregnant women, and in children when combined with amodiaquine, is threatened by the …

Sulfadoxine-pyrimethamine (SP) resistance impairs the efficacy of antimalarial drugs.
Monitoring molecular markers in exported malaria infections provides an efficient way to …

Background Sulfadoxine–pyrimethamine (SP) is recommended for intermittent preventive
treatment of malaria in Africa. However, increasing SP resistance (SPR) affects the …

Background Despite significant progress in eliminating malaria from the Kingdom of Saudi
Arabia, the disease is still endemic in the southwestern region of the country. Artesunate …

Background Anti-malarial drug resistance remains a key concern for the global fight against
malaria. In Ghana sulfadoxine-pyrimethamine (SP) is used for intermittent preventive …

Sulfadoxine/pyrimethamine (SP) is still used for malaria control in sub-Saharan Africa;
however, widespread resistance is a major concern. This study aimed to determine the …

Purpose Antimalarial drug resistance is one of the major challenges in global efforts to
control and eliminate malaria. In 2006, sulfadoxine-pyrimethamine (SP) replaced with …

Background Plasmodium falciparum is the predominant human malaria species in
Mozambique and a lead cause of mortality among children and pregnant women …

Ethiopia changed the first-line anti-malarial drug for uncomplicated Plasmodium falciparum
malaria from sulfadoxine–pyrimethamine (SP) to Coartem® in 2004 following nation-wide …

Background Despite various efforts to control malaria among children, the disease remains
a leading cause of morbidity and mortality worldwide. In the Sahel region, including Burkina …